Practical aspects of fast reversed-phase high-performance liquid chromatography using 3 μm particle packed columns and monolithic columns in pharmaceutical development and production working under current good manufacturing practice

The potential and limitations of fast reversed-phase high-performance liquid chromatographic separations for assay and purity of drug substances and drug products were investigated in the pharmaceutical industry working under current good manufacturing practice using particle packed columns and monolithic columns. On particle packed columns, the pressure limitation of commercially available HPLC systems was found to be the limiting factor for fast separations. On 3 μm particle packed columns, HPLC run times (run to run) for assay and purity of pharmaceutical products of 20 min could be achieved. As an interesting alternative, monolithic columns were investigated. Monolithic columns can be operated at much higher flow rates, thus allowing for much shorter run times compared to particle packed columns. Compared to particle packed columns, the analysis time could be reduced by a factor up to 6. However, some compounds investigated showed a dramatic loss of efficiency at higher flow rates. This phenomenon was observed for some larger molecules supporting the theory that mass transfer is critical for applications on monolithic columns. At flow rates above 3 ml/min some HPLC instruments showed a dramatic increase in noise, making quantifications at low levels impossible. For very fast separations on monolithic columns, the maximum data acquisition rate of the detector is the limiting factor.